0 followers
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther... Read more
Bruce Culleton
The Max Foundation
1 follower
Boston Scientific
81 followers
RQI Partners, LLC
1 follower
GRAIL
27 followers
Cytokinetics
11 followers
OPEN MINDS Circle
2 followers
American Academy of Physician Associates
1 follower
Function Health
1 follower
Outset Medical
5 followers
Emergent BioSolutions
4 followers
SpringWorks Therapeutics
4 followers
Discover companies